Lung-on-chip platforms investigate the preference of TNBC and HER2+ cells to spread into lung, while liver-on-chip platforms recapitulates the breast cancer liver metastasis, emphasizing the premetastatic niche formation as well as the role of BC-derived EVs in liver metastasis. This evidence concerns the gene ERBB2 and breast carcinoma.